Trials / Recruiting
RecruitingNCT04852198
Comparing 150cm OAGB With 150cm Biliopancreatic Limb RYGB. A Non-inferiority Trial
A Study on Safety and Efficacy Comparing 150cm One Anastomosis Gastric Bypass With 150cm Biliopancreatic Limb Roux-en-Y Gastric Bypass (Roux-en-WHY?): An Open Label, Multicentre Non-inferiority Randomized Controlled Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 298 (estimated)
- Sponsor
- Flevoziekenhuis · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety and efficiency of OAGB compared to RYGB
Detailed description
Rationale: to compare two different types of gastric bypass operations on surgical outcome. Objective: to compare two established procedures in order to find the optimal procedure in terms of weight loss and metabolic control that is associated with the fewest side-effects and complications, and decreased invasiveness. Study design: A multicentre, open label, non-inferiority randomized controlled trial Study population: Patients are eligible for inclusion if their body-mass index (BMI) was 40 kg/m2 or higher, or 35 kg/m2 or higher with the presence of at least one comorbidity (type 2 diabetes, high blood pressure, obstructive sleep apnoea, dyslipidaemia, osteoarthritis of the hip or knee) and a positive evaluation by our bariatric multidisciplinary team (BMDT) and are aged 18-65. Intervention: Group 1: One Anastomosis Gastric Bypass with 150cm biliopancreatic limb. Group 2: Roux-en-Y gastric bypass with biliopancreatic limb of 150cm and 75cm alimentary limb. Main study parameters/endpoints: Primary endpoint: % Excess BMI loss at two years Secondary endpoints: Metabolic status Nutritional status Comorbidity remission QOL Complications or serious adverse events (SAE's)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | OAGB | Simplified gastric bypass procedure |
| PROCEDURE | RYGB | Roux-en-Y gastric bypass. Standard procedure in the Netherlands |
Timeline
- Start date
- 2021-12-13
- Primary completion
- 2027-06-13
- Completion
- 2029-11-01
- First posted
- 2021-04-21
- Last updated
- 2024-04-23
Locations
2 sites across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT04852198. Inclusion in this directory is not an endorsement.